,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #efaf ,,in ,,the ,,house ,,of ,,representatives ,april #be1 #bjah ,ms4 ,clarke of ,new ,york 7for herself1 ,mr4 ,rush1 ,mr4 ,butterfield1 and ,ms4 ,kelly of ,illinois7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to require the ,national ,institute of ,minority ,health and ,health ,disparities to submit to ,congress a report on the impact of the opioid epidemic on minority communities4 #a4 ,short title ,this ,act may be cited as the ,opioid ,minority ,health ,report to ,congress ,act of #bjah4 #b4 ,national ,institute of ,minority ,health and ,health ,disparities report on the impact of the opioid epidemic on minority communities ,not later than one year after the date of the enactment of this ,act1 and annually thereafter1 the ,national ,institute of ,minority ,health and ,health ,disparities shall submit to the ,committee on ,finance of the ,senate and the ,committees on ,ways and ,means and ,energy and ,commerce of the ,house of ,representatives1 and make public on the ,internet website of ,department of ,health and ,human ,services1 a report on the impact of the opioid epidemic on racial and ethnic minority groups 7as defined in section #agjg7;g7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjju-#f7;g7771 including the following3 7#a7 ,the scope of the epidemic within such racial and ethnic minority groups with respect to the use of prescription pain killers and illicit drug use1 including synthetics4 7#b7 ,the extent to which1 and funding recommendations for how1 the expansion of coverage under the ,medicare program under title ,,xviii of the ,social ,security ,act and the ,medicaid program under title ,,xix of such ,act of medication-assisted treatment and other treatment options could decrease the incidence of opioids use and of deaths caused by opioids overdoses4 7#c7 ,the role of participation of such racial and minority groups in clinical trials for pain management therapy and alternatives to opioids pain management and recommendations on how to increase such participation of such groups in such clinical trials4